[1]周 涛.Ⅱ、Ⅲ期直肠癌Ki-67及微卫星不稳定的表达对预后的影响[J].医学信息,2021,34(23):66-68.[doi:10.3969/j.issn.1006-1959.2021.23.018]
　ZHOU Tao.Effect of Ki-67 and Microsatellite Instability on Prognosis in Stage Ⅱ and Ⅲ Rectal Cancer[J].Medical Information,2021,34(23):66-68.[doi:10.3969/j.issn.1006-1959.2021.23.018]
点击复制

Ⅱ、Ⅲ期直肠癌Ki-67及微卫星不稳定的表达对预后的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年23期
页码:
66-68
栏目:
论著
出版日期:
2021-12-01

文章信息/Info

Title:
Effect of Ki-67 and Microsatellite Instability on Prognosis in Stage Ⅱ and Ⅲ Rectal Cancer
文章编号:
1006-1959（2021）23-0066-03
作者:
周 涛
（泰州市第二人民医院普外科，江苏 泰州 225500）
Author(s):
ZHOU Tao
(Department of General Surgery,Taizhou Second People’s Hospital,Taizhou 225500,Jiangsu,China)
关键词:
直肠癌; 微卫星不稳定性; Ki-67; 预后
Keywords:
Rectal cancer; Microsatellite instability; Ki-67; Prognosis
分类号:
R735.3
DOI:
10.3969/j.issn.1006-1959.2021.23.018
文献标志码:
A
摘要:
目的 分析Ⅱ、Ⅲ期直肠癌Ki-67及微卫星不稳定的表达对预后的影响。方法 将我院2019年3月-2021年3月共65例结肠癌患者作为研究对象，分析错配修复蛋白表达情况、微卫星不稳定性与直肠癌临床特征、生存期之间的关系以及Ki-67与直肠癌临床特征、生存期之间的关系。结果 MLH1表达缺失11例，MSH2表达缺失14例，MSH6表达缺失8例，PMS2表达缺失7例。Ki-67表达阳性48例，阴性17例。微卫星不稳定性与肿瘤直径、淋巴结转移以及TNM分期有关（P＜0.05）；微卫星不稳定性患者总生存期高于微卫星稳定性患者（P＜0.05）；Ki-67与肿瘤直径、淋巴结转移以及TNM分期有关（P＜0.05）；Ki-67阳性患者总生存期高于Ki-67阴性患者（P＜0.05）。结论 Ki-67阴性及微卫星不稳定表达有利于延长Ⅱ、Ⅲ期直肠癌患者的总生存期，主要与肿瘤直径、淋巴结转移、TNM分期有关。
Abstract:
Objective To analyze the effects of Ki-67 and microsatellite instability on the prognosis of stage Ⅱ and Ⅲ rectal cancer.Methods A total of 65 colon cancer patients in our hospital from March 2019 to March 2021 were used as the research objects to analyze the expression of mismatch repair proteins, the relationship between microsatellite instability and the clinical characteristics of rectal cancer, survival, and the relationship between Ki-67 and rectal cancer clinical features and survival period.Results There were 11 cases of MLH1 expression loss, 14 cases of MSH2 expression loss, 8 cases of MSH6 expression loss, and 7 cases of PMS2 expression loss. Ki-67 expression was positive in 48 cases and negative in 17 cases. Microsatellite instability was related to tumor diameter, lymph node metastasis and TNM stage (P<0.05). The total survival time of patients with microsatellite instability was higher than patients with microsatellite instability (P<0.05). Ki-67 was related to tumor diameter, lymph node metastasis and TNM stage (P<0.05). The total survival time of Ki-67 positive patients was higher than that of Ki-67 negative patients (P<0.05).Conclusion Ki-67 negative and microsatellite instability expression are conducive to prolonging the overall survival of patients with stage Ⅱ and Ⅲ rectal cancer, which are mainly related to tumor diameter, lymph node metastasis and TNM staging.

参考文献/References:

[1]吴国访,段红霞,张丽.丹参川芎嗪注射液联合长春西汀治疗颅内动脉瘤的临床研究[J].中西医结合心脑血管病杂志,2020,18(16):2730-2733.[2]Yoshikawa K,Shimada M,Higashijima J,et al.Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy[J].Anticancer Res,2018,38(3):1735-1739.[3]张胡磊.中医辨证后实施丹参注射液和川穹嗪注射液治疗偏头痛的疗效[J].北方药学,2018,15(9):92-93.[4]张翔,杨觅,胡静,等.结直肠癌中C-MET、COX-2、MSS、Ki-67的表达及其与预后的相关性分析[J].解放军预防医学杂志,2018,36(5):598-601.[5]Hasan S,Renz P,Wegner RE,et al.Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis[J].Ann Surg,2020,271(4):716-723.[6]马春涛,许春芳,张海玲.错配修复蛋白和Ki-67在结直肠癌中的表达及其临床意义[J].胃肠病学,2019,24(1):39-42.[7]罗长顺,刘坤,汪黎明.肿瘤微环境相关因子与直肠癌新辅助化疗效果及微卫星稳定状况的关系[J].癌症进展,2020,18(10):1031-1034.[8]Fan S,Li X,Zheng L,et al.Correlations between the iodine concentrations from dual energy computed tomography and molecular markers Ki-67 and HIF-1α in rectal cancer: A preliminary study[J].Eur J Radiol,2017(96):109-114.[9]冯强,孙琦,孙霞,等.微卫星不稳定性及错配修复蛋白表达与结直肠癌化疗疗效相关性的研究[J].东南大学学报(医学版),2020,39(6):793-799.[10]黎相照,刘焕娇,梁敏仪,等.微卫星不稳定性类型及临床病理特征:基于1394例结直肠癌患者的标本检测[J].南方医科大学学报,2020,40(11):1645-1650.[11]Bi L,Li Y,Guo Q,et al.Effect of Neoadjuvant Chemotherapy With FOLFOX4 on Expressions of Ki-67, MMP-2 and Fas in Rectal Cancer[J].Chinese Journal of Gastroenterology,2017,22(11):658-661.[12]王玉.结直肠癌组织中EGFR、Ki-67蛋白的表达及其与临床病理特征的关系研究[J].辽宁医学杂志,2021,35(1):42-45.[13]Du C,Zhao J,Xue W,et al.Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy[J].Histopathology,2013,62(5):723-730.[14]郭源,张龙,张舜,等.结直肠癌错配修复蛋白表达及微卫星不稳定与TNM分期的相关性[J].肿瘤研究与临床,2019,31(6):376-380.[15]夏丹丹,王惠宇,许隽颖,等.不同部位大肠癌患者K-ras基因突变与临床病理特征及预后的关系[J].肿瘤研究与临床,2018,30(9):586-591.[16]黎琪,张标,牛丰南,等.合并结直肠癌双原发癌患者的临床病理特征,MSI及K-ras基因突变分析[J].中华医学杂志,2020,100(4):301-306.[17]常静,刘继红,强玲,等.结直肠癌新辅助化疗与微卫星不稳定相关性研究[J].中华肿瘤防治杂志,2018,25(14):31-36.[18]陈浩林,彭昌兵,杜镇鸿,等.散发性结直肠癌患者错配修复蛋白表达情况以及微卫星不稳定性与Rb蛋白表达的相关性研究[J].解放军医药杂志,2018,213(3):54-57.[19]谭林,陈维顺,周红兵,等.结直肠癌中GRHL3、E-cadherin和Ki-67的表达及临床意义[J].临床与实验病理学杂志,2021,37(1):71-74.

相似文献/References:

[1]王梦荷,闵 利,李亚玲.Roy适应模式对直肠癌Miles术后结肠造口患者适应水平及家庭负担影响的研究[J].医学信息,2018,31(09):163.[doi:10.3969/j.issn.1006-1959.2018.09.054]
　WANG Meng-he,MIN Li,LI Ya-ling.Effect of Roy Adaptation Mode on Adaptation Level and Family Burden of Colostomy Patients after Rectal Cancer Miles Operation[J].Medical Information,2018,31(23):163.[doi:10.3969/j.issn.1006-1959.2018.09.054]
[2]张淑贞.永久性肠造口患者延续性护理的研究进展[J].医学信息,2018,31(11):63.[doi:10.3969/j.issn.1006-1959.2018.11.020]
　ZHANG Shu-zhen.Research Progress of Continuing Nursing for Patients with Permanent Enterostomy[J].Medical Information,2018,31(23):63.[doi:10.3969/j.issn.1006-1959.2018.11.020]
[3]蔡 彬,黄 伟,储正达,等.直肠腔内超声与相控阵线圈磁共振在直肠癌术前局部分期中的Meta分析[J].医学信息,2019,32(10):70.[doi:10.3969/j.issn.1006-1959.2019.10.024]
　CAI Bin,HUANG Wei,CHU Zheng-da,et al.Meta-analysis of Intra-rectal Ultrasound and Phased-array Magnetic Resonance in the Preoperative Partial Phase of Rectal Cancer[J].Medical Information,2019,32(23):70.[doi:10.3969/j.issn.1006-1959.2019.10.024]
[4]刘 峰,吴晓丽,谢建军.腹腔镜直肠癌全系膜切除术对直肠癌患者远期排尿功能的影响[J].医学信息,2020,33(04):104.[doi:10.3969/j.issn.1006-1959.2020.04.031]
　LIU Feng,WU Xiao-li,XIE Jian-jun.Effect of Laparoscopic Total Mesorectal Excision on Rectal Cancer Patients with Long-term Urination Function[J].Medical Information,2020,33(23):104.[doi:10.3969/j.issn.1006-1959.2020.04.031]
[5]杨建国,陈清伟,李金豆,等.直肠癌新辅助放化疗与手术间隔时间对临床和肿瘤学结局的影响[J].医学信息,2020,33(10):90.[doi:10.3969/j.issn.1006-1959.2020.10.024]
　YANG Jian-guo,CHEN Qing-wei,LI Jin-dou,et al.Effects of Neoadjuvant Radiochemotherapy and Operation Interval of Rectal Cancer on Clinical and Oncological Outcomes[J].Medical Information,2020,33(23):90.[doi:10.3969/j.issn.1006-1959.2020.10.024]
[6]王 辉,刘爱芬.NOTES腹腔镜下直肠癌根治术治疗直肠癌的效果[J].医学信息,2020,33(17):95.[doi:10.3969/j.issn.1006-1959.2020.17.027]
　WANG Hui,LIU Ai-fen.The Effect of Laparoscopic Radical Resection of Rectal Cancer in the Treatment of Rectal Cancer by NOTES[J].Medical Information,2020,33(23):95.[doi:10.3969/j.issn.1006-1959.2020.17.027]
[7]梁 杨,胡燕华,王 梅,等.直肠癌术后患者性功能障碍的影响因素及护理现状[J].医学信息,2020,33(23):52.[doi:10.3969/j.issn.1006-1959.2020.23.016]
　LIANG Yang,HU Yan-hua,WANG Mei,et al.Influencing Factors and Nursing Status of Patients with Sexual Dysfunction After Rectal Cancer Operation[J].Medical Information,2020,33(23):52.[doi:10.3969/j.issn.1006-1959.2020.23.016]
[8]刘 俊,严 婷,刘 红,等.2013~2019年广州某院消化系统恶性肿瘤流行病学分析[J].医学信息,2020,33(23):137.[doi:10.3969/j.issn.1006-1959.2020.23.040]
　LIU Jun,YAN Ting,LIU Hong,et al.Epidemiological Analysis of Malignant Tumors of the Digestive System in a Hospital in Guangzhou from 2013 to 2019[J].Medical Information,2020,33(23):137.[doi:10.3969/j.issn.1006-1959.2020.23.040]
[9]徐跃心,吕文豪,杨长青,等.妊娠合并胃肠道恶性肿瘤3例临床分析[J].医学信息,2021,34(03):190.[doi:10.3969/j.issn.1006-1959.2021.03.056]
[10]侯丁丁,赵 力.Ⅱ~Ⅲ期结肠癌术后辅助化疗方案[J].医学信息,2021,34(18):6.[doi:10.3969/j.issn.1006-1959.2021.18.002]
　HOU Ding-ding,ZHAO Li.Adjuvant Chemotherapy After Surgery for Stage Ⅱ~Ⅲ Colon Cancer[J].Medical Information,2021,34(23):6.[doi:10.3969/j.issn.1006-1959.2021.18.002]

更新日期/Last Update: 1900-01-01